NO20031995D0 - Fremgangsmåte - Google Patents

Fremgangsmåte

Info

Publication number: NO20031995D0
Authority: NO; Norway
Prior art keywords: compounds; ammonium; approach; azasteroids; steriods
Prior art date: 2000-11-03

Application number

NO20031995A

Other languages

English (en)

Other versions

NO20031995L (no

NO325180B1 (no

Inventor

Roman Davis

Alan Millar

Thomas Jeffrey Sterbenz

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-03

Filing date

2003-05-02

Publication date

2003-05-02

2003-05-02 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2003-05-02 Publication of NO20031995L publication Critical patent/NO20031995L/no

2003-05-02 Publication of NO20031995D0 publication Critical patent/NO20031995D0/no

2008-02-11 Publication of NO325180B1 publication Critical patent/NO325180B1/no

Links

150000001875 compounds Chemical class 0.000 abstract 2
USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 abstract 1
239000005695 Ammonium acetate Substances 0.000 abstract 1
229940123934 Reductase inhibitor Drugs 0.000 abstract 1
229940043376 ammonium acetate Drugs 0.000 abstract 1
235000019257 ammonium acetate Nutrition 0.000 abstract 1
VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 abstract 1
XJMWHXZUIGHOBA-UHFFFAOYSA-N azane;propanoic acid Chemical compound N.CCC(O)=O XJMWHXZUIGHOBA-UHFFFAOYSA-N 0.000 abstract 1
239000003054 catalyst Substances 0.000 abstract 1
238000005984 hydrogenation reaction Methods 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
-1 steroid alkene Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Steroid Compounds (AREA)
Glass Compositions (AREA)
Iron Core Of Rotating Electric Machines (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Valve Device For Special Equipments (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20031995A 2000-11-03 2003-05-02 Fremgangsmate for fremstilling av 3-okso-4-azasteroid og anvendelse derav NO325180B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0026876.3A GB0026876D0 (en)	2000-11-03	2000-11-03	Process
PCT/US2001/048173 WO2002046207A2 (en)	2000-11-03	2001-11-02	Process

Publications (3)

Publication Number	Publication Date
NO20031995L NO20031995L (no)	2003-05-02
NO20031995D0 true NO20031995D0 (no)	2003-05-02
NO325180B1 NO325180B1 (no)	2008-02-11

Family

ID=9902484

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031995A NO325180B1 (no)	2000-11-03	2003-05-02	Fremgangsmate for fremstilling av 3-okso-4-azasteroid og anvendelse derav

Country Status (23)

Country	Link
US (1)	US6794508B2 (no)
EP (1)	EP1335930B1 (no)
JP (1)	JP4257117B2 (no)
KR (1)	KR100821018B1 (no)
CN (1)	CN1313480C (no)
AT (1)	ATE279429T1 (no)
AU (2)	AU4162402A (no)
BR (1)	BR0115089A (no)
CA (1)	CA2427709A1 (no)
DE (1)	DE60106482T2 (no)
DK (1)	DK1335930T3 (no)
ES (1)	ES2230383T3 (no)
GB (1)	GB0026876D0 (no)
HU (1)	HUP0303907A3 (no)
IL (2)	IL155078A0 (no)
MX (1)	MXPA03003925A (no)
NO (1)	NO325180B1 (no)
NZ (1)	NZ525168A (no)
PL (1)	PL206539B1 (no)
PT (1)	PT1335930E (no)
SI (1)	SI1335930T1 (no)
WO (1)	WO2002046207A2 (no)
ZA (1)	ZA200302560B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100503193B1 (ko)	2002-08-19	2005-07-25	한미약품 주식회사	3-옥소-4-아자-5α-안드로스탄 화합물의 선택적인 제조방법
WO2005075497A1 (en) *	2004-01-07	2005-08-18	Ranbaxy Laboratories Limited	PROCESS FOR THE PREPARATION OF 17ß-SUBSTITUTED-3-OXO-4-AZA-5ALPHA-ANDROSTANE DERIVATIVES
CN100355772C (zh) *	2005-12-28	2007-12-19	天津大学	具有5α－还原酶抑制活性的甾体化合物及其制备方法
AR070313A1 (es)	2008-01-03	2010-03-31	Gador Sa	Un procedimiento para preparar una forma solida y cristalina de dutasteride, una forma polimorfica del compuesto (forma iii) y una composicion farmaceutica que incluye dicha forma
HU230730B1 (hu)	2011-06-30	2017-12-28	Richter Gedeon Nyrt	Eljárás (5alfa,17béta)-N-[2,5-bisz-(trifluormetil)-fenil]-3-oxo-4-aza-5-androszt-1-én-17-karbonsavamid előállítására
CN103059097A (zh) *	2011-10-20	2013-04-24	连云港润众制药有限公司	一种度他雄胺中间体的制备方法
CN103254268A (zh) *	2013-05-16	2013-08-21	寿光市富康化学工业有限公司	一种制备度他雄胺的工艺
CN104231033B (zh) *	2014-09-17	2016-08-24	广东众生药业股份有限公司	一种度他雄胺的制备方法
CN108051513B (zh) *	2017-11-27	2020-09-29	重庆华邦制药有限公司	Hplc法分离测定度他雄胺起始原料sm2及其相关杂质的方法
CN109438549B (zh) *	2018-12-13	2022-01-04	湖北葛店人福药业有限责任公司	一种制备N-叔丁基-3-氧代-4-氮杂-5α-雄甾-17β-甲酰胺的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ211145A (en) *	1984-02-27	1988-10-28	Merck & Co Inc	4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
GB2264494A (en) *	1992-02-25	1993-09-01	Merck & Co Inc	17b-n-monosubstituted carbamoyl-11-oxo-4-aza-5-a-androst-1-en-3-one testosterone-5-alpha reductase inhibitors
TW408127B (en) *	1993-09-17	2000-10-11	Glaxo Inc	Androstenones

2000
- 2000-11-03 GB GBGB0026876.3A patent/GB0026876D0/en not_active Ceased
2001
- 2001-11-02 DK DK01988307T patent/DK1335930T3/da active
- 2001-11-02 SI SI200130241T patent/SI1335930T1/xx unknown
- 2001-11-02 US US10/415,922 patent/US6794508B2/en not_active Expired - Fee Related
- 2001-11-02 JP JP2002547944A patent/JP4257117B2/ja not_active Expired - Fee Related
- 2001-11-02 CA CA002427709A patent/CA2427709A1/en not_active Abandoned
- 2001-11-02 AU AU4162402A patent/AU4162402A/xx active Pending
- 2001-11-02 MX MXPA03003925A patent/MXPA03003925A/es active IP Right Grant
- 2001-11-02 CN CNB018184960A patent/CN1313480C/zh not_active Expired - Fee Related
- 2001-11-02 EP EP01988307A patent/EP1335930B1/en not_active Expired - Lifetime
- 2001-11-02 AT AT01988307T patent/ATE279429T1/de active
- 2001-11-02 PL PL365705A patent/PL206539B1/pl not_active IP Right Cessation
- 2001-11-02 KR KR1020037006176A patent/KR100821018B1/ko not_active Expired - Fee Related
- 2001-11-02 ES ES01988307T patent/ES2230383T3/es not_active Expired - Lifetime
- 2001-11-02 PT PT01988307T patent/PT1335930E/pt unknown
- 2001-11-02 NZ NZ525168A patent/NZ525168A/en not_active IP Right Cessation
- 2001-11-02 HU HU0303907A patent/HUP0303907A3/hu unknown
- 2001-11-02 AU AU2002241624A patent/AU2002241624B2/en not_active Ceased
- 2001-11-02 BR BR0115089-8A patent/BR0115089A/pt not_active Application Discontinuation
- 2001-11-02 DE DE60106482T patent/DE60106482T2/de not_active Expired - Lifetime
- 2001-11-02 WO PCT/US2001/048173 patent/WO2002046207A2/en not_active Ceased
- 2001-11-02 IL IL15507801A patent/IL155078A0/xx unknown
2003
- 2003-03-25 IL IL155078A patent/IL155078A/en not_active IP Right Cessation
- 2003-04-01 ZA ZA200302560A patent/ZA200302560B/en unknown
- 2003-05-02 NO NO20031995A patent/NO325180B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
MXPA03003925A (es)	2003-08-19
WO2002046207A3 (en)	2003-03-20
US20040049042A1 (en)	2004-03-11
EP1335930A2 (en)	2003-08-20
PL365705A1 (en)	2005-01-10
IL155078A0 (en)	2003-10-31
SI1335930T1 (en)	2005-04-30
ES2230383T3 (es)	2005-05-01
PL206539B1 (pl)	2010-08-31
AU4162402A (en)	2002-06-18
KR100821018B1 (ko)	2008-04-08
JP4257117B2 (ja)	2009-04-22
WO2002046207A2 (en)	2002-06-13
PT1335930E (pt)	2005-01-31
ATE279429T1 (de)	2004-10-15
KR20030081326A (ko)	2003-10-17
NZ525168A (en)	2005-03-24
AU2002241624B2 (en)	2004-10-28
HK1058799A1 (en)	2004-06-04
NO20031995L (no)	2003-05-02
BR0115089A (pt)	2003-10-07
DE60106482D1 (de)	2004-11-18
GB0026876D0 (en)	2000-12-20
HUP0303907A2 (hu)	2004-03-01
DK1335930T3 (da)	2005-02-14
DE60106482T2 (de)	2005-10-13
US6794508B2 (en)	2004-09-21
CN1313480C (zh)	2007-05-02
IL155078A (en)	2009-06-15
CA2427709A1 (en)	2002-06-13
HUP0303907A3 (en)	2012-09-28
ZA200302560B (en)	2004-04-01
JP2004515505A (ja)	2004-05-27
EP1335930B1 (en)	2004-10-13
CN1473165A (zh)	2004-02-04
NO325180B1 (no)	2008-02-11

Similar Documents

Publication	Publication Date	Title
BRPI0113670B8 (pt)	2021-05-25	composição farmacêutica e método para tratar hipogonadismo
ATE255589T1 (de)	2003-12-15	Kristallin form i von clarithromycin
DE69828958D1 (de)	2005-03-17	Arzneiformulierungen zur hormonersatztherapie zur topischen anwendung auf der haut
PT1196414E (pt)	2003-12-31	Pro-farmacos de inibidores carbamato de impdh
NO20031995D0 (no)	2003-05-02	Fremgangsmåte
HN2001000217A (es)	2002-06-13	Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa - 7
BRPI0113286B8 (pt)	2021-05-25	pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
DE69816280D1 (de)	2003-08-14	Inhibitoren des impdh-enzyms
DK1235571T3 (da)	2005-01-17	Anvendelse af melatonin til behandling af androgenetisk eller diffus alopecia af feminin type
NO20050091L (no)	2005-04-06	Fremgangsmater for fremstilling av fibrinogen
DE60021113D1 (de)	2005-08-04	Albumin-bindende verbindungen die die nichtenzymatische glycosylierung verhindern und die zur behandlung von glycosylierungsbedingten erkrankungen verwendet werden können
MXPA03002495A (es)	2004-05-05	Proceso para preparacion de compuestos de n-(fenil sustituido)-3-alquil, aril- y heteroarilsulfonil-2-hidroxi-2-alquil- y haloalquilpropanamida.
DK0991424T3 (da)	2001-12-03	Farmaceutiske præparater omfattende en inhibitor for aldosereduktase og en inhibitor for ACE
SI1347764T1 (sl)	2007-06-30	Gelni sestavek na alkoholni osnovi za zdravljenje hipogonadizma s trans-skrotalno aplikacijo
BR0115359A (pt)	2003-08-26	Método para a preparação de uma composição catalisadora e seu uso em um processo de polimerização
BR0016638B1 (pt)	2013-02-05	compostos anÁlogos de homopiperidilbenzimidazàis substituÍdos como relaxantes féndicos, processo para preparar os mesmos, composiÇço farmacÊutica e processo para preparÁ-la.
SE0100857D0 (sv)	2001-03-13	Treatment of tumors
ATE322244T1 (de)	2006-04-15	Verwendung von polyaminosäurederivaten zur behandlung von seborrhoe und verwandten hautstörungen
AU2001231849A1 (en)	2001-07-24	Use of dehydroepiandrosterone and/or precursors or derivatives thereof to improve papery aspect of the skin
DK1444247T3 (da)	2007-09-24	Tibolonformuleringer
DE50112512D1 (de)	2007-06-28	Phenanthridinderivate und phenanthridin enthaltende antitumorale arzneimittel
GB957541A (en)	1964-05-06	5ª‡-steroids
UA34406A (uk)	2001-02-15	Засіб для лікування розсіяного склерозу, спосіб лікування з його використанням та фармацевтична упаковка
ECSP003799A (es)	2001-07-27	Nuevos esteroides con actividad androgenica y su uso como anticonceptivos masculinos y para tratar la insuficiencia androgenica.

Legal Events

Date	Code	Title	Description
2013-06-24	MM1K	Lapsed by not paying the annual fees